Why More Medicine Can Mean Less Health, and Why Cleaner Air Teaches the Same Lesson

Jul 05, 2026

10 min read

2 views

67%

The Strange Art of Removing What You Cannot See

What if the most effective intervention is not the one that looks the most impressive, but the one that quietly removes what should not be there?

That question sits at the center of two domains that rarely get discussed together: indoor air quality and modern medicine. In one, a plant is valued not for spectacle but for its capacity to absorb invisible pollutants like benzene, formaldehyde, xylene, and trichloroethylene. In the other, the grand promise of healthcare is complicated by a stubbornly uncomfortable finding: across large populations, more spending on medicine often does not translate into better health.

At first glance, these ideas seem unrelated. One is about a houseplant. The other is about hospitals, doctors, and billions of dollars. But both point toward the same deeper lesson: systems often fail not because they lack activity, but because they confuse activity with effective cleanup.

We tend to trust what is visible. A hospital visit feels meaningful because it is concrete, urgent, and expensive. A plant quietly filtering air seems modest, even quaint. Yet both examples challenge the same instinct. The right question is not, “How much is happening?” The right question is, “What harmful things are being removed, and does their removal actually change outcomes?”

The Seduction of Visible Intervention

Human beings are drawn to interventions that announce themselves. If you can see the machine, the procedure, the prescription, or the bustling activity, it feels serious. That is one reason healthcare systems keep expanding in complexity, and why patients often equate more treatment with better care.

But visibility is a terrible proxy for value. A room can be crowded with effort and still remain unhealthy. A clinic can be busy and still produce little marginal benefit. A living space can contain elegant decor and still be filled with microscopic toxins. What matters is not the drama of the intervention, but the physics of what it changes.

This is where the plant metaphor becomes unexpectedly powerful. A plant does not argue with the air. It does not perform improvement. It simply participates in a process that alters the environment in ways most people never notice directly. The work is subtle, and because it is subtle, it is easy to underestimate.

Medicine often suffers from the opposite error. We see the treatment, not the counterfactual. We see the antibiotic, the scan, the consult, the surgery. We do not see the patient who would have recovered anyway, the test that changed nothing, or the intervention whose benefit is swallowed by noise. In a population, this matters enormously. The larger the system, the more likely we are to mistake visible action for measurable gain.

The great mistake of complex systems is to reward interventions that feel decisive even when they barely move the outcome.

The deeper tension is not between care and no care. It is between symbolic intervention and effective intervention. One reassures us. The other actually changes the environment.

Why Large Numbers Expose Uncomfortable Truths

One of the most provocative ideas in modern health economics is that when you look at healthcare spending across large groups, the average medical effect can be surprisingly small. That does not mean medicine is useless. It means that, in aggregate, the relationship between inputs and outcomes is far weaker than our intuitions expect.

This is emotionally difficult because medicine comes attached to moral seriousness. Doctors save lives. Hospitals treat the wounded. Antibiotics are one of humanity’s most celebrated breakthroughs. Surely, then, more care should mean better health. Yet the aggregate picture keeps pushing back. The reason is not mysterious once you think in terms of systems.

Healthcare is not one thing. It is a mix of lifesaving interventions, marginal tests, defensive medicine, overdiagnosis, monitoring, patient preference, and treatments that are useful in some contexts but unnecessary in others. Average spending therefore bundles together high-value care with low-value care, and the low-value portion can dominate the marginal dollar.

The key distinction is between common care and marginal care. Common care includes the ordinary, routine medical activity that people actually receive. Marginal care is the extra layer, the next test, the next consultation, the next escalation. The uncomfortable question is whether those extra layers consistently buy health.

The answer often appears to be no. And the reason this shocks people is that we instinctively assume doctors can identify when care matters most. But if the biggest gains come from situations where illness is obvious, then surely medicine should shine there. Yet that is not always what the data suggest. In practice, the boundary between necessary treatment and low-yield intervention is murky.

This is where a second analogy helps. Imagine a building with an air purifier that removes only a subset of pollutants. If you add more fans, more filters, and more gadgets without knowing which contaminants are actually present, you may create the appearance of sophistication without materially improving the air. Healthcare can work like that. The system becomes elaborate, but the core problem remains partly untouched.

The lesson is not that medicine should retreat into fatalism. It is that we dramatically overestimate our ability to notice which interventions are doing the real work.

The Invisible Enemy Problem

Both indoor pollution and disease present the same epistemic problem: the enemy is often invisible.

You cannot always smell benzene or formaldehyde. You may feel perfectly fine in a room where the air is quietly burdened with compounds that irritate or harm over time. Likewise, you may leave a doctor’s office relieved without any clear sense of whether the treatment improved your trajectory or merely satisfied your need for action.

This creates a dangerous illusion. When the target is invisible, people overvalue visible proxies. In air quality, those proxies might be the presence of a plant, the hum of a purifier, or the scent of cleanliness. In medicine, they might be the number of appointments, the sophistication of the imaging, or the intensity of the treatment plan. But proxy satisfaction is not the same as hazard reduction.

A useful mental model here is the filter versus theater distinction:

Filter: changes the underlying environment in a way that improves long-run outcomes.
Theater: produces reassuring signs of activity without meaningful environmental change.

A plant can be a filter if it actually reduces certain airborne toxins. A scan can be theater if it changes nothing about treatment and merely adds anxiety. A prescription can be a filter if it targets a real, relevant pathogen. It can be theater if it is given because action feels safer than restraint.

The point is not that all visible interventions are theater. The point is that visibility is cheap, and efficacy is hard. Our institutions often reward the former more readily than the latter.

This is why large studies are so important. They strip away the stories that individual cases tell. A single dramatic recovery can make a treatment seem miraculous. A single bad outcome can make it seem dangerous. But the aggregate does something more honest: it asks whether the intervention changes the shape of the distribution. If it does not, then the ritual of treatment may be obscuring reality.

The Antibiotic Paradox and the Myth of Obvious Progress

Few examples reveal this tension more sharply than antibiotics. They are among the most celebrated achievements in medicine, and deservedly so. But the existence of dramatic success in some contexts can lead us to overgeneralize. We begin to believe that medicine as a whole behaves like its greatest triumphs.

That is a category error.

Antibiotics are not a proof that every additional medical intervention is similarly powerful. They are proof that when you hit the right mechanism at the right time, the effect can be extraordinary. The mistake is to convert that lesson into a universal expectation of benefit.

This is what makes healthcare so hard to reason about. Medicine contains both miracles and noise, but they are interwoven at the point of use. The patient and the doctor rarely know in advance which one they are dealing with. That uncertainty encourages escalation. If some intervention sometimes saves lives, then withholding it feels dangerous. Yet if many interventions have small average effect, then routine escalation becomes a costly habit.

The real challenge is not choosing between action and inaction. It is learning how to discriminate between high-leverage intervention and ceremonial excess.

Think again about air purification. A room full of ornamental plants may feel healthier, but the true question is whether the concentration of harmful compounds changes enough to matter. One plant may be modestly helpful. Ten plants may not be ten times better. At some point, you are decorating a room, not cleaning it.

Healthcare often has the same shape. The first intervention may have meaningful benefit. The tenth may just increase complexity. The difference is hidden because each additional step feels incremental and therefore harmless. But accumulation creates cost, risk, and distraction.

A Better Framework: Clean the Environment, Not the Anxiety

If both clean air and better medicine depend on removing invisible harms, what should we do differently?

The answer is to shift from intervention counts to environmental quality. In practice, that means asking a harder set of questions:

What harmful thing are we trying to remove?
How do we know it is present?
Does this intervention remove enough of it to matter?
What new harms does the intervention introduce?
Are we improving the environment, or merely soothing our fear?

This framework applies elegantly to both domains. In a home, the goal is not to own more plants or devices. The goal is to lower exposure to pollutants in a way that persists. That might involve ventilation, source control, filtration, and only then supplemental plants. A plant becomes part of an ecosystem of cleanup, not a talisman.

In medicine, the goal is not to maximize care. The goal is to maximize health. That may mean aggressive treatment in some cases, but restraint in others. It may mean prioritizing prevention, diagnosis, or simple interventions over repeated escalation. It may also mean admitting that some forms of medical spending buy very little, especially at the margin.

The most mature systems, whether biological or institutional, are not the ones that do the most. They are the ones that waste the least energy on irrelevant activity while preserving enough capacity to respond when it truly matters.

Good systems are not those that always act. Good systems are those that know when action changes the environment.

That may sound obvious, but it is surprisingly rare in practice. Organizations love measurable output. Patients love visible effort. Governments love budgets. All three can grow while the underlying problem stays stubbornly similar.

Key Takeaways

Stop counting interventions and start measuring environmental change. The real question is not whether something was done, but whether it reduced the harmful exposure or risk.
Be suspicious of visible effort that lacks a clear mechanism. A busy system can still be ineffective if it cannot explain what it is removing or improving.
Separate high-value care from low-value care. In medicine, more spending often mixes life-saving treatment with marginal add-ons. The average hides the difference.
Use counterfactual thinking. Ask what would have happened without the plant, the test, the prescription, or the procedure. That is where value becomes visible.
Favor source control over symbolic cleanup. Whether you are improving air or health, removing the source of harm usually matters more than layering on more visible fixes.

The Real Lesson: Systems Fail When They Reward Reassurance Over Removal

The deepest connection between a plant that quietly helps clean indoor air and a healthcare system that often fails to convert spending into health is this: both remind us that outcomes depend on what is actually removed, not on how much effort is displayed.

We want the world to reward urgency, expertise, and visible action. Sometimes it does. But often the more important work is less dramatic. It is filtration, not performance. It is subtraction, not accumulation. It is the patient elimination of invisible harms.

That reframes how we should think about both health and medicine. The best intervention is not necessarily the most advanced, the most expensive, or the most immediate. It is the one that meaningfully changes the conditions under which health is won or lost.

And perhaps that is the most counterintuitive insight of all: sometimes the truest form of care is not to add more, but to remove what should never have been there in the first place.